Skip to content

Correlation of Local Microbiota in the Nucleus Pulposus with Gut Microbiota and Metabolic Characteristics in Patients with Intervertebral Disc Herniation

Correlation of Local Microbiota in the Nucleus Pulposus with Gut Microbiota and Metabolic Characteristics in Patients with Intervertebral Disc Herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127729
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-06
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intervertebral Disc Herniation

Interventions

Observation Group of Intervertebral Disc Protrusion Syndrome:None

Sponsors

Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 and above, who have signed the informed consent form; 2. Meet the diagnostic criteria for cervical, thoracic, and lumbar intervertebral disc protrusion; 3. Plan to undergo surgical treatment, and during the operation, a nucleus pulposus sample can be obtained; 4. Can complete fecal and peripheral blood collection before the surgery.

Exclusion criteria

Exclusion criteria: 1.Recent use of antibiotics, probiotics, or other drugs/preparations that significantly affect gut microbiota; 2.Concurrent active infection, severe gastrointestinal dysfunction, tumor, immune system disease, spinal infection, pregnancy, severe hepatic or renal insufficiency, etc. 3.Prior history of spinal surgery, significant post-traumatic deformity, or congenital spinal deformity; 4.Predominantly manifesting as obvious myelopathy and not suitable for pain stratification; 5.Inability to cooperate with sample collection; 6.Unqualified nucleus pulposus, fecal, or blood samples;

Design outcomes

Primary

MeasureTime frame
Changes in microbiota between nucleus pulposus samples and fecal samples;

Secondary

MeasureTime frame
Correlation between microbiota and metabolites;Multivariable associations between microbiota, metabolites, and clinical baseline characteristics;Association between microbiota, metabolites, and VAS score;Multi-omics integrated analysis results of fecal microbiome, fecal metabolome, nucleus pulposus microbiome, nucleus pulposus metabolome, and nucleus pulposus transcriptome;Differences in the metabolome of nucleus pulposus, feces, and blood;Correlation between nucleus pulposus microbiota and fecal microbiota;

Countries

China

Contacts

Public ContactHanbin Wang

Hangzhou First People's Hospital

458154923@qq.com+86 15757119331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026